1.Isolation of gardnerelia vaginalis and application of 4 diagnostic criteriae in bacterial vaginosis.
Korean Journal of Obstetrics and Gynecology 1991;34(12):1725-1733
No abstract available.
Vaginosis, Bacterial*
2.Investigation of phylogroups and some virulence traits among cervico-vaginal Escherichia coli (CVEC) isolated for female in Hilla City, Iraq
Marwa Mohammed Al-Khaqani ; Mourouge Saadi Alwash ; Hussein Oleiwi Al-Dahmoshi
Malaysian Journal of Microbiology 2017;13(2):132-138
Aims: This study aims to investigate the phylogroups, antibiotics susceptibility and biofilm formation among CVEC
isolated from female with bacterial vaginosis.
Methodology and results: High vaginal swab from girl with age (18-60 years) were collected and cultured on
MacConkey agar, EMB agar and UTI chromogenic medium to recover CVEC and only the confirmed Escherichia coli will
pass through rest of the assays like phylogrouping (by PCR), antibiotics susceptibility test and biofilm formation. The
results revealed that only 32 (20.38%) of CVEC were recovered and among them only 3 (9.375%) of CVEC belong to
intestinal subgroup A1 and the rest 29 (90.625%) assigned to extraintestinal phylogenetic group B2. CVEC isolates
belong to B1 and D groups not reported. Antibiotics resistance results shown that, 32 (100%) for cefazolin, cephalothin,
cefoxitin and metronidazole, 31 (96.9%) for erythromycin, 24 (75%) for fosfomycin, 20 (62.5%) for cefotaxime, 16 (50%)
for ceftazidime, 14 (43.75%) for cefepeim, (28.1%) for aztreonam, 7 (21.9%) for streptomycin, 6 (18.75%) for
meropenem, 5 (15.6%) for both imipenem and gentamicin, 2 (6.25%) for both ciprofloxacin and norfloxacin, amikacin 1
(3.1%) and no resistance stated for nitrofurantion (0.00%). TCP methods results display that 12 (37.5%) of CVEC were
biofilm former while 20 (62.5%) were non biofilm former.
Conclusion, significance and impact of study: This study concluded that, most of the CVEC belong to highly virulent
phylogroup B2 and have the ability to resist multiple antibiotics and the ciprofloxacin, norfloxacin, amikacin and
nitrofurantion still the best choice for treatment and CVEC have the ability to form biofilm which make the infection
ruthless and hard to cure.
Vaginosis, Bacterial
3.Bacterial vaginitis at the Institute of Dermato-verereology in the years 2001 - 2002
Journal of Practical Medicine 2003;459(9):27-28
The study carries on 1209 female patients from 16 to 55 years old at dermatology of dermatological hospital. These patients were tested to diagnose infected Bacteria vaginosis (BV), in particular, they were candled directly under optical microscope with enlargement 1000X to discover BV. The results were the rate infectious BV is the highest at the age group 26 – 35 (2.58%), and the age group 35 – 45 (2.4%), the possitive rate of the age group 26 – 45 is 4.98%. The total of infected patients is 27/1209 patients (2.23%). The rate infected BV of this research is much less than some studies of European countries as Poland, Swede, Belgium, England...
Vaginitis
;
Vulvitis
;
Vaginosis, Bacterial
4.Usefullness of gram stain diagnosing bacterial vaginosis in korean women of reproductive age.
Hong Soo KIM ; Kyung SEO ; Yong Won LEE ; Yeon Suk RHEE ; Joung In YANG ; Yoon Ho LEE ; Kook LEE
Korean Journal of Obstetrics and Gynecology 1993;36(7):2957-2966
No abstract available.
Female
;
Humans
;
Vaginosis, Bacterial*
5.Correlation of Diagnostic 4 Signs, Bacterial Vaginosis and Gardnerella vaginalis Isolation and Drug - resistant Profiles of Clinical Isolates.
Nam Woong YANG ; Yong LIM ; Sung Heui SHIN
Journal of the Korean Society for Microbiology 2000;35(5):354-354
No Abstract Available.
Gardnerella vaginalis*
;
Gardnerella*
;
Vaginosis, Bacterial*
6.Correlation of Diagnostic 4 Signs, Bacterial Vaginosis and Gardnerella vaginalis Isolation and Drug - resistant Profiles of Clinical Isolates.
Nam Woong YANG ; Yong LIM ; Sung Heui SHIN
Journal of the Korean Society for Microbiology 2000;35(5):354-354
No Abstract Available.
Gardnerella vaginalis*
;
Gardnerella*
;
Vaginosis, Bacterial*
7.The incidence of genital Mycoplasmas infection in premenopausal women with gynecologic symptoms.
Korean Journal of Obstetrics and Gynecology 2008;51(10):1142-1147
OBJECTIVE: This study was to evaluate the incidence of genital Mycoplasmas Infection in Korean premenopausal women with gynecologic symptoms METHODS: Between January 2006 and December 2006, vaginal specimens from 90 premenopausal patients with gynecologic symptoms were obtained for analysis of genital Mycoplasmas infection using multiplex PCR. RESULTS: The incidence of M. hominis, U. urealyticum, and M. genitalicum infection was 44.4%, 18.9% and 2.2% respectively. From patients with non-foul odored vaginal discharge, M. hominis, and, U. urealyticum were detected in 37.8% and 17.8% respectively. From patients with bacterial vaginosis who had foul odored vaginal discharge, M. hominis, U. urealyticum, and M. genitalicum were detected in 71.4%, 14.3% and 4.8% respectively. From patients with PID or FHC syndrome, M. hominis, U. urealyticum, and M. genitalicum were detected in 43.8%, 37.5% and 6.3% respectively. CONCLUSION: The incidence of Mycoplasmas infection from vaginal specimens of Korean premenopausal women with gynecologic symptoms was about 66%. Especially, 56% of patients with non-foul odored vaginal discharge, 90% with bacterial vaginosis, and 88% with PID or FHC syndrome showed Mycoplasmas infection, so we suggest the consideration of Mycoplasmas infection as cause of gynecologic symptoms.
Female
;
Humans
;
Incidence
;
Mycoplasma
;
Odors
;
Vaginal Discharge
;
Vaginosis, Bacterial
8.Vaginal microbiota transplantation for treatment of bacterial vaginosis: a review.
Chinese Journal of Biotechnology 2021;37(11):3820-3827
Bacterial vaginosis (BV) is a disease caused by vaginal microbiota dysbiosis. The conventional antibiotic treatment can aggravate microbial dysbiosis, alter the acid environment of the vagina and lead to drug resistance, thus shows low cure rate and high recurrence rate. This poses significant physiological and psychological burden to the BV patients. Vaginal microbiota transplantation (VMT) is a novel live biotherapeutic approach. It directly engrafts the whole vaginal microbiota from healthy women to the vaginal tract of patients to rapidly reconstruct the vaginal microbiota environment and restore the vaginal health. This article summarizes the development, present challenges, and future directions of using VMT, with the aim to explore new strategies for treatment of BV and promote the clinical use of VMT.
Dysbiosis/therapy*
;
Female
;
Humans
;
Microbiota
;
Vagina
;
Vaginosis, Bacterial/therapy*
10.Prevalence of bacterial vaginosis in married women of reproductive age in the rural area of Shandong province and its risk factors.
Hui-Bo CHEN ; Lan-Ying ZHOU ; Hui-Qing LI ; Hong-Qing LIU ; Shu-Qi DING ; Min ZHAO
Acta Academiae Medicinae Sinicae 2006;28(3):378-381
OBJECTIVETo explore the prevalence of bacterial vaginosis of married women of reproductive age in the rural area of Shandong province and its affecting factors, with an aim to provide references for setting up preventing measures for this disease.
METHODSA stratified, population-based, cluster sampling method was employed. The epidemiological investigation on bacterial vaginosis of married women of reproductive age was carried out at four sampling fields.
RESULTSThe prevalence of bacterial vaginosis was 6.64%. The main risk factors included: lacked of personal bathtub and towel; did not use sterilized paper on menstrual phase; had no knowledge that gonorrhea, syphilis, AIDS, and trichomonal vaginitis can be transmitted through sexual intercourse.
CONCLUSIONThe prevalence of bacterial vaginosis in married women of reproductive age in Shandong rural area is high, which correlates with the lower education level, limited health knowledge, and unhealthy behavior.
Adult ; China ; epidemiology ; Female ; Humans ; Middle Aged ; Prevalence ; Risk Factors ; Rural Health ; Vaginosis, Bacterial ; epidemiology